How Global Health’s AI-Driven SaaS Shift Is Reshaping Digital Healthcare in FY25

Global Health Limited reports solid progress towards profitability in FY2025, driven by a 6% increase in subscription revenue and strategic AI integration across its healthcare platforms.

  • Subscription revenue rises 6% to $6.325 million
  • EBITDAR reaches $1.335 million, representing 18% of revenue
  • EBITDA loss narrows by 37% to $760,000 after fully expensed R&D
  • 30 new clients signed, expanding SaaS platform adoption
  • AI integration reduces support tickets by over 35% and improves response times
An image related to Global Health Limited
Image source middle. ©

Financial Performance and Growth

Global Health Limited (ASX – GLH) has demonstrated encouraging progress in its FY2025 financial results, marking a clear trajectory back to profitability. Subscription revenue increased by 6% to $6.325 million, supported by the onboarding of 30 new clients ranging from large multi-location providers to smaller service operators. This client expansion fueled a 16% rise in new SaaS revenue, underscoring the growing market acceptance of the company’s digital health platforms.

The company reported an EBITDAR of $1.335 million, equating to 18% of revenue, a notable operating margin that excludes research and development expenses. Despite still recording an EBITDA loss of $760,000 after fully expensed R&D, this represents a 37% improvement compared to the prior year, reflecting disciplined cost management and operational efficiencies.

Strategic Technology Transition and AI Integration

A key highlight of Global Health’s FY25 was the ongoing transition from legacy on-premise applications to a multi-tenant, cloud-based SaaS architecture. This shift is designed to enhance scalability, security, and user experience across its flagship products such as MasterCare Plus, HotHealth, ReferralNet, and Lifecard.

Complementing this technological upgrade is a robust embrace of artificial intelligence. The company has integrated AI-driven workflows internally and across its platforms, including AI avatars for customer support that have resolved over 70% of tickets with minimal human intervention. These initiatives have led to a 35% reduction in support ticket volumes and significantly improved response and resolution times, boosting customer satisfaction and operational productivity.

Market Position and Forward Outlook

Global Health’s solutions address critical challenges in Australia’s healthcare system, particularly the management of chronic diseases that account for nearly half of all disease spending. Its patient-centric ecosystem aims to empower consumers through personal health records and seamless clinician connectivity, aligning with national frameworks promoting digital health and home-based care.

Looking ahead, the company plans to complete its SaaS platform transition by mid-2026 and intensify revenue development efforts. This includes expanding indirect sales channels both domestically; leveraging partnerships like the one with Best Practice, a dominant GP system provider; and internationally. The Lifecard Personal Health Record is positioned as a key growth driver, targeting consumer empowerment and engagement across multiple care settings.

Management remains confident that the combination of technological innovation, AI adoption, and strategic partnerships will enhance shareholder value while addressing the escalating demands of healthcare providers and consumers alike.

Bottom Line?

Global Health’s AI-powered SaaS transformation sets the stage for accelerated growth and deeper market penetration in FY2026.

Questions in the middle?

  • How will the completion of the SaaS migration impact recurring revenue and client retention?
  • What measurable outcomes will AI integration deliver in clinical decision-making and patient care?
  • How quickly can Global Health scale its international sales channels beyond early discussions?